141 related articles for article (PubMed ID: 9648833)
21. The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance.
Frittitta L; Baratta R; Spampinato D; Di Paola R; Pizzuti A; Vigneri R; Trischitta V
J Clin Endocrinol Metab; 2001 Dec; 86(12):5888-91. PubMed ID: 11739459
[TBL] [Abstract][Full Text] [Related]
22. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
Stefanović V; Antić S
Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
[TBL] [Abstract][Full Text] [Related]
23. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.
Goldfine ID; Maddux BA; Youngren JF; Reaven G; Accili D; Trischitta V; Vigneri R; Frittitta L
Endocr Rev; 2008 Feb; 29(1):62-75. PubMed ID: 18199690
[TBL] [Abstract][Full Text] [Related]
24. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome.
Corbould A; Dunaif A
Metabolism; 2007 May; 56(5):716-22. PubMed ID: 17445549
[TBL] [Abstract][Full Text] [Related]
25. Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance.
Dong H; Maddux BA; Altomonte J; Meseck M; Accili D; Terkeltaub R; Johnson K; Youngren JF; Goldfine ID
Diabetes; 2005 Feb; 54(2):367-72. PubMed ID: 15677494
[TBL] [Abstract][Full Text] [Related]
26. Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Study of mechanisms in muscle and in rat-1 fibroblasts overexpressing the human insulin receptor.
Robinson KA; Sens DA; Buse MG
Diabetes; 1993 Sep; 42(9):1333-46. PubMed ID: 8349045
[TBL] [Abstract][Full Text] [Related]
27. Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation.
Spampinato D; Giaccari A; Trischitta V; Costanzo BV; Morviducci L; Buongiorno A; Di Mario U; Vigneri R; Frittitta L
Metabolism; 2003 Sep; 52(9):1092-5. PubMed ID: 14506612
[TBL] [Abstract][Full Text] [Related]
28. Analysis of insulin-stimulated insulin receptor activation and glucose transport in cultured skeletal muscle cells from obese subjects.
Pender C; Goldfine ID; Kulp JL; Tanner CJ; Maddux BA; MacDonald KG; Houmard JA; Youngren JF
Metabolism; 2005 May; 54(5):598-603. PubMed ID: 15877289
[TBL] [Abstract][Full Text] [Related]
29. Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Evidence for an abnormality specific to glucose metabolism.
Wells AM; Sutcliffe IC; Johnson AB; Taylor R
Diabetes; 1993 Apr; 42(4):583-9. PubMed ID: 8384133
[TBL] [Abstract][Full Text] [Related]
30. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators.
Li M; Youngren JF; Dunaif A; Goldfine ID; Maddux BA; Zhang BB; Evans JL
J Clin Endocrinol Metab; 2002 Sep; 87(9):4088-93. PubMed ID: 12213853
[TBL] [Abstract][Full Text] [Related]
31. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
[TBL] [Abstract][Full Text] [Related]
32. Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo.
Zhou HH; Chin CN; Wu M; Ni W; Quan S; Liu F; Dallas-Yang Q; Ellsworth K; Ho T; Zhang A; Natasha T; Li J; Chapman K; Strohl W; Li C; Wang IM; Berger J; An Z; Zhang BB; Jiang G
Eur J Pharmacol; 2009 Aug; 616(1-3):346-52. PubMed ID: 19577557
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors of insulin receptor tyrosine kinase in fibroblasts from diverse patients with impaired insulin action: evidence for a novel mechanism of postreceptor insulin resistance.
Maddux BA; Sbraccia P; Reaven GM; Moller DE; Goldfine ID
J Clin Endocrinol Metab; 1993 Jul; 77(1):73-9. PubMed ID: 7686917
[TBL] [Abstract][Full Text] [Related]
34. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
Sakoda H; Ogihara T; Anai M; Funaki M; Inukai K; Katagiri H; Fukushima Y; Onishi Y; Ono H; Yazaki Y; Kikuchi M; Oka Y; Asano T
Diabetes; 1999 Jul; 48(7):1365-71. PubMed ID: 10389840
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiology of insulin resistance.
Sesti G
Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):665-79. PubMed ID: 17161338
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors.
Abate N; Chandalia M; Di Paola R; Foster DW; Grundy SM; Trischitta V
Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):694-701. PubMed ID: 17143316
[TBL] [Abstract][Full Text] [Related]
37. [Membrane glycoprotein PC-1 and insulin resistance].
Teno S; Iwamoto Y
Nihon Rinsho; 1997 Nov; 55 Suppl():812-6. PubMed ID: 9434569
[No Abstract] [Full Text] [Related]
38. Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.
Stefanovic V; Djordjevic V; Ivic M; Mitic-Zlatkovic M; Vlahovic P
Ann Clin Biochem; 2005 Jan; 42(Pt 1):55-60. PubMed ID: 15802034
[TBL] [Abstract][Full Text] [Related]
39. The inhibition of the insulin receptor by the receptor protein PC-1 is not specific and results from the hydrolysis of ATP.
Stefan C; Wera S; Stalmans W; Bollen M
Diabetes; 1996 Jul; 45(7):980-3. PubMed ID: 8666152
[TBL] [Abstract][Full Text] [Related]
40. [Glycoprotein PC-1].
Teno S; Iwamoto Y
Nihon Rinsho; 2002 Jul; 60 Suppl 7():621-5. PubMed ID: 12238108
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
